Epigallocatechin

Epigallocatechin (EGC) is a flavan-3-ol catechin found predominantly in green tea that exerts antioxidant effects by scavenging reactive oxygen species and chelating metal ions. It inhibits viral replication and demonstrates antineoplastic activity primarily through modulation of oxidative signaling pathways and enzyme inhibition.

Origin & History

Epigallocatechin (EGC) is a polyphenolic catechin primarily sourced from green tea leaves (Camellia sinensis), where it occurs alongside other catechins like epicatechin. It is also isolated from the stem bark of Spondias mombin, a plant used in West African folk medicine.

Historical & Cultural Context

Epigallocatechin is a component of Spondias mombin, which is used in Nigerian and West African folk medicine for treating severe infections and health disorders. However, specific traditional uses of EGC itself are not documented.

Health Benefits

• Acts as a strong inhibitor of HIV replication in vitro, indicating potential antiviral properties (Preliminary evidence).
• Exhibits powerful antioxidant activity, contributing to reduced oxidative stress (Preliminary evidence).
• Demonstrates antineoplastic properties in plant extracts (Preliminary evidence).
• May provide anti-inflammatory effects due to its antioxidative capabilities (Preliminary evidence).
• Supports general health as part of the polyphenol content in green tea extracts (based on related catechin studies, Preliminary evidence).

How It Works

Epigallocatechin neutralizes free radicals by donating hydrogen atoms from its polyhydroxyl groups, directly scavenging superoxide anion, hydroxyl radicals, and peroxyl radicals. It inhibits HIV replication in vitro partly by interfering with reverse transcriptase activity and disrupting viral entry mechanisms at the host cell membrane. Additionally, EGC modulates pro-inflammatory signaling by inhibiting NF-κB pathway activation and suppressing cyclooxygenase-2 (COX-2) expression, contributing to its antineoplastic and anti-inflammatory effects.

Scientific Research

The research lacks specific human clinical trials or meta-analyses focused solely on epigallocatechin. Most evidence pertains to its gallate ester, EGCG, with no PMIDs available for EGC-specific studies.

Clinical Summary

Most evidence for epigallocatechin derives from in vitro cell culture studies and animal models rather than robust human clinical trials, placing its benefits firmly in the preliminary category. In vitro studies have demonstrated HIV-1 reverse transcriptase inhibition and cytotoxic effects against several cancer cell lines including HeLa and MCF-7 breast cancer cells. Human data are largely extrapolated from green tea intervention trials, where the broader catechin fraction — not isolated EGC — is studied, limiting attribution of specific outcomes to EGC alone. Antioxidant biomarker improvements observed in green tea studies (e.g., reduced 8-OHdG urinary levels) cannot be solely credited to EGC without isolated compound trials.

Nutritional Profile

Epigallocatechin (EGC) is a pure polyphenolic compound (flavan-3-ol/catechin subclass), not a whole food, so traditional macronutrient/micronutrient profiling does not apply. Molecular formula: C15H14O7, molecular weight: 306.27 g/mol. As a bioactive compound, it contains no protein, fat, or fiber intrinsically. Key structural features include a trihydroxylated B-ring and a dihydroxylated A-ring with a hydroxyl group at the C-3 position (distinguishing it from its gallate ester form, EGCG). Found naturally in green tea (Camellia sinensis) at approximately 5–10 mg per gram of dry leaf weight, typically lower in concentration than its more studied ester form EGCG (which ranges 50–100 mg/g dry leaf). Also present in smaller quantities in white tea, oolong tea, fruits such as apples and grapes, and certain legumes. Bioavailability is limited due to poor intestinal absorption, susceptibility to oxidation at alkaline pH, and extensive first-pass metabolism; oral bioavailability estimated at less than 5% in human studies. Undergoes methylation, glucuronidation, and sulfation by phase II enzymes in the intestinal wall and liver. Colonic microbiota further metabolize EGC into phenolic acids (e.g., 5-(3,4,5-trihydroxyphenyl)-γ-valerolactone). Consumption of vitamin C (ascorbic acid) in the same matrix has been shown to partially stabilize EGC and modestly improve bioavailability. No caloric, mineral, or vitamin content is attributable to EGC as an isolated compound.

Preparation & Dosage

No clinically studied dosage ranges or specific forms for epigallocatechin are available. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Epicatechin, EGCG, Vitamin C, Quercetin, Resveratrol

Safety & Interactions

Epigallocatechin is generally regarded as safe when consumed through dietary green tea, but concentrated supplement doses above 800 mg/day of total catechins have been associated with hepatotoxicity in rare case reports. It may inhibit iron absorption by chelating non-heme iron in the gut, posing a concern for individuals with iron-deficiency anemia. EGC can interact with anticoagulants such as warfarin by mildly inhibiting platelet aggregation, and caution is advised when combining with other antioxidant supplements at high doses. Safety data in pregnant and breastfeeding women are insufficient, and conservative avoidance of high-dose supplementation during pregnancy is recommended.